Ulrich Specks
Professor of Medicine · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History
Research
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism · 2013 · 4,922 citations
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
New England Journal of Medicine · 2010 · 2,067 citations
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine · 2017 · 801 citations
115 papers
77 papers
71 papers
69 papers
- JS
69 papers
69 papers
62 papers
- GH
60 papers
Grants
- 2002–2007
PR3-ANCA Subsets and Disease Phenotype
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1M · Mayo Clinic Rochester
- 2003–2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $15.2K · Mayo Clinic Rochester
- 1999–2002
Effects of pr3-Anca on Disease Phenotype
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $309.3K · Mayo Clinic Rochester
Clinical trials
- 2026–2028
Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube
Principal investigator · Recruiting · Phase 1
Mayo Clinic
- 2023–2024
- 2005–2010
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Study chair · Completed · Phase 2, Phase 3
National Institute of Allergy and Infectious Diseases (NIAID)